Table 1.
Demographic and clinical data of patients and controls groups.
| Patients (N) % | Controls (N) % | P value | |||
|---|---|---|---|---|---|
| Sex | |||||
| Female | 24 (48%) | 14 (28%) |
0.0637* | ||
| Male | 26 (52%) | 36 (72%) | |||
| Hepatomegaly | 25 (50%) | 4 (3%) | <0.0001*** | ||
| Splenomegaly | 42 (84%) | 4 (3%) | <0.0001*** | ||
| Lymphadenopathy | 27 (54%) | 2 (1%) | <0.0001*** | ||
| Age (years) | Range | Mean ± SD | Range | Mean ± SD | |
| 18–68 | 45.8 ± 12.7 | 20–63 | 38.2 ± 11.8 | 0.25* | |
N: number of subjects. *Not significant (NS) (P value > 0.05), **significant (S) (P value < 0.05), ***highly significant (HS) (P value < 0.0001).